Not another yes-or-no verdict. A verifiable map of what the evidence actually says, how certain it is, and why studies disagree.
The signal is more consistent for processed than unprocessed meat. Individual risk still depends on baseline consumption and personal risk factors.
Association ≠ causation. A statistical relationship may still reflect confounding or measurement error.
Hazard ≠ individual risk. An IARC classification does not tell you how much one person’s risk changes.
Compared with what? Replacing meat with legumes is not the same as replacing it with refined carbohydrates.
One cohort reported model-estimated absolute differences as well as hazard ratios. Change the horizon and exposure to see why a percentage without time and comparator is incomplete.
more Cardiovascular disease
events per 1,000 people over 30 years
95% confidence interval: +8.5–+26.3 / 1,000 · +1.7 percentage points
2 vs 0 servings of processed meat per week
No explicit replacement food. Other foods were adjusted for, so this cannot answer “replace with legumes, fish or refined grains?”
A model-estimated association for a cohort with average covariates—not an individual forecast and not proof of a causal effect.
A preregistered meta-analysis compared specified substitutions. Select what replaces 50 g/day of processed meat; the outcome is total cardiovascular disease.
associated with a 27% lower relative hazard
95% confidence interval: 0.59–0.91 · 8 cohorts
50 g/day processed meat → 28–50 g/day nuts
The source did not provide one shared baseline risk and time horizon. Converting this relative estimate into an absolute number would require assumptions the study did not report.
GRADE was moderate for these three estimates, but every included publication was observational and none was judged at low risk of bias.
Nine claims across four articles. We preserve the valid methodological criticism—and mark where the reasoning outruns the evidence.
The warning about relative risk is useful; the conversion is not.
Headlines should show baseline and absolute risk, not only a large relative number.
The paper followed 216,695 people and reported 22,761 cases. Its headline 1.62 was a hazard ratio comparing extreme intake quintiles in a model that intentionally omitted BMI as a possible mediator. Adding time-varying BMI reduced the estimate to 1.23.
Cases divided by person-years are incidence rates, not each participant’s cumulative absolute probability. A hazard ratio is not a risk ratio. Calling roughly 0.29 versus 0.52 cases per 100 person-years “absolute risk” mixes incompatible quantities and hides the important BMI sensitivity analysis.
Exposure misclassification is real; the proposed alternative cause was not tested.
Mixed dishes and self-reported diet make it harder to isolate the effect of meat itself.
The exposure definition did include processed-meat sandwiches and beef, pork or lamb in sandwiches or mixed dishes. But diet was reassessed every 2–4 years, averaged cumulatively, adjusted for refined grains and overall diet, and calibrated against two 7-day weighed records in 1,207 participants.
FFQ error weakens precision; it does not show that bread or oil generated the association. That would require a component-level or substitution analysis. The published exposure list supports “mixed dishes,” not the claim that lasagna was the causal driver.
Baseline imbalance is a limitation, not a complete refutation.
Higher-meat participants differed in smoking, alcohol, BMI and diet. Residual confounding cannot be eliminated.
The 474,996-person UK Biobank analysis adjusted for smoking, BMI, activity, deprivation, alcohol, fibre, fruit, vegetables, dairy and fish; calibrated amounts with repeated 24-hour recalls in 69,076 people; excluded early cases and reran analyses in never-smokers; and corrected for 22 outcome tests.
After those checks, colorectal cancer was the only robust cancer signal; most other associations disappeared after multiple-testing correction. The honest conclusion is “observational signal with residual uncertainty,” not “the baseline table disproves it.”
A rat surrogate experiment became a human treatment implication.
Animal models can test mechanisms and sometimes produce results that challenge a prior hypothesis.
One hundred carcinogen-initiated rats ate diets containing 30% or 60% freeze-dried cooked meat for 100 days. The endpoint was aberrant crypt foci, a putative precancerous marker—not human cancer, survival or treatment of an existing tumour.
The authors themselves proposed that bacon’s salt increased water intake and diluted promoting compounds; they explicitly warned about transfer from this rat model and surrogate endpoint. The study cannot support advice that bacon prevents or treats human colorectal cancer.
Particle modification matters, but it is not a prerequisite for LDL causality.
Oxidation, glycation, inflammation and particle characteristics affect atherosclerotic biology and individual risk.
More than 200 prospective, genetic, Mendelian-randomization and randomized-treatment studies—over 2 million participants and 150,000 cardiovascular events—show concordant dose- and time-dependent effects of LDL/apoB particle exposure.
That triangulation is not explained away by saying only modified LDL matters. Nor does LDL causality prove that one food has a fixed effect: cut, saturated-fat content, replacement food and the whole diet still determine the dietary comparison.
A country-level correlation cannot identify an individual dietary effect.
Cross-country data can challenge simplistic universality and generate hypotheses about context.
The comparison uses national meat supply/consumption and national life expectancy. Those variables also move with income, sanitation, infant mortality, healthcare access, smoking history, urbanization and many other exposures.
Inferring what happens to individuals from grouped national averages is the ecological fallacy. It is methodologically weaker than the individual-level cohorts Hoole rejects and cannot establish that meat caused longevity—or that moderate intake is harmful.
Large individual-level international comparison ↗Hoole’s article ↗
Two national trends moving in opposite directions do not isolate causation.
Long-term trends should be compatible with a proposed causal story and can reveal contradictions worth investigating.
The argument compares aggregate intake with a broad, undefined category of chronic disease over decades. It also excludes pork from red meat by personal definition, unlike standard epidemiologic classifications.
Population aging, obesity, smoking latency, diagnosis, survival, exercise, total calories and the rest of the diet all changed. Without outcome-specific age-standardized rates and a design controlling those trends, the graph neither proves harm nor safety.
Hoole’s time-trend argument ↗IARC’s standard red-meat definition ↗
A real sampling limitation is fused with the wrong historical dataset.
The Seven Countries cohorts were purposively, not randomly, selected; external validity and unmeasured cultural differences are legitimate limitations.
The famous 22-country comparison was a separate, earlier ecological dataset. The later Seven Countries Study began in 1958 as a prospective study of 16 cohorts and 12,763 men using standardized individual measurements and follow-up.
Saying Keys removed 15 outcome-inconvenient countries from the prospective study conflates two projects. Correcting that history does not turn the Seven Countries Study into a randomized trial or make it sufficient, by itself, to settle diet–heart causality.
Seven Countries Study design ↗Historical review ↗Hoole’s article ↗
Nutrient density is not evidence of long-term completeness or safety.
Red meat is protein- and micronutrient-dense, and adequacy depends on cuts, organs, total energy and individual needs.
The article relies on nutrient composition, evolutionary narrative and personal experience. It does not cite a long-duration controlled comparison of an all-red-meat diet measuring deficiency, cardiovascular, cancer and mortality outcomes.
A table of nutrients cannot establish absorption, requirements across populations, long-term clinical outcomes or the safety of excluding all other foods. The categorical prescription exceeds the evidence even if short-term experiences are positive.
The 2023 diabetes cohort was NIH-funded, declared no author conflicts, repeated diet measures and used calibration—but remains observational and its headline estimate is BMI-sensitive.
A 2022 meta-analysis found no overall short-term glycemic harm. Beef Checkoff funded it, commented on early design, and the authors’ employer had beef and pork-board funding. Most trials lasted 4–8 weeks.
A 2026 preregistered review found meat-industry-tied studies far more likely to publish favorable conclusions (OR 16.4). That does not invalidate each paper; it makes methods and wording—not sponsor labels alone—the unit of audit.
These 16 decision-relevant sources and 9 claim audits demonstrate the product; they are not yet a complete systematic review. The full corpus will be deduplicated, checked by two reviewers and published under a preregistered protocol.
A questionnaire completed once twenty years ago is not equivalent to repeated diaries or biomarkers.
Potential impact: highMeat versus legumes can yield a different answer than meat versus white bread or a similar diet.
Potential impact: very highSmoking, income, physical activity and overall diet quality may move together with meat intake.
Potential impact: highA sponsor can shape the question, comparator, duration and conclusion without falsifying the numbers.
Analyze it; never use it as an automatic vetoThese products are adjacent, not interchangeable. A review publisher, an AI search tool and a clinical reference solve different jobs.
They commission, synthesize and publish evidence—not merely search it.
Rigorous reviews, living evidence or unusually strong consumer nutrition summaries.
What it does not replaceUsually organized around review questions or reference topics—not a public audit trail from a viral claim through calculations, funding, comparators and sensitivity choices.
They assess influential public claims and reasoning.
Expert scrutiny, clear verdicts and excellent checks of whether citations support a claim.
What it does not replaceMostly reactive claim, article or book reviews; not a continuously updated, outcome-by-outcome evidence model with sensitivity analyses.
They help users find, screen, extract or contextualize papers.
Scale and speed: discovery, AI extraction, citation context and evidence filtering.
What it does not replaceThey are research instruments. They generally do not assume editorial responsibility for a durable public conclusion and its correction history.
They turn evidence into point-of-care guidance for clinicians.
Continuous expert editing, clinical context and actionable graded recommendations.
What it does not replaceDesigned for professional decisions, commonly subscription-based, and not built to dissect polarizing public narratives or expose a topic-wide funding graph.
They expose post-publication criticism, corrections, retractions or participant-level data.
Essential checks on the scientific record and paths to independent reanalysis.
What it does not replaceThese are inputs to an evidence audit, not consumer-facing syntheses of what a disputed health claim currently means.
Full competitor matrix and source notes are versioned in the project.
A plain-language conclusion, certainty level and the most important caveat appear before the technical detail.
Readers can see how comparator, study design, funding or exclusion choices change the conclusion.
Every sentence points back to the study, method, data availability and revision history behind it.
AI accelerates the work; it does not get the final word. Every step keeps its source, version, confidence and human review.
Databases, registries, gray literature and multiple languages
One study, even when it produces many papers
Methods and numbers linked to the original page
Two reviewers and design-specific tools
Alternative analyses, funding and sensitivity
New studies without erasing version history
Searches, exclusions, extractions and analyses have a verifiable history.
Funding and sponsor roles become queryable data, not footnotes.
Every evidence card can be challenged with sources; revisions stay public.
Every daily review records what was searched, what changed and whether the conclusion moved. An unchanged conclusion is still a result—not a reason to erase the check.
Added a preregistered substitution meta-analysis and a 2025 Finnish pooled-cohort study. The new comparator lens shows that replacing 50 g/day of processed meat with nuts, legumes or whole grains produced different relative estimates. It also states why those estimates cannot be turned into events per 1,000 without a shared baseline risk and time horizon, and why the observational design does not establish causality.
Added the study’s fully adjusted 10-, 20- and 30-year absolute risk differences per 1,000 people. The view keeps exposure contrast and implicit comparator visible, and flags that the unprocessed-meat/CVD association crossed the null in a competing-risk model. These are cohort estimates, not personal predictions or causal effects.
Added a processed-meat umbrella review, while keeping its low to very low certainty visible. Disclosed the NutriRECS correction, checked nine core DOIs against the current Crossref / Retraction Watch dataset, and reviewed indexed PubPeer signals. No retraction or expression of concern was found in the records checked.
First concept for onde.media · Pilot topic: red meat